Related Experiment Video
Updated: Jul 6, 2026

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
Published on: February 25, 2016
Pediatric SARS-CoV-2 long term outcomes study (PECOS): cross sectional analysis at baseline
Gina A Montealegre Sanchez1, Lauren E Arrigoni2,3, Alexandra B Yonts3,4,5
1Division of Clinical Research (DCR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. montealegrega@nih.gov.
Insights
Children infected with SARS-CoV-2 reported more symptoms and worse quality of life compared to uninfected children. This ongoing study, Pediatric COVID-19 Conquer Study (PECOS), will track long-term effects of COVID-19 in pediatric populations.
Area of Science:
- Pediatric infectious diseases
- Longitudinal cohort studies
- COVID-19 outcomes
Background:
- The Pediatric COVID-19 Conquer Study (PECOS) investigates long-term outcomes of SARS-CoV-2 infection in children.
- Characterizing post-COVID-19 conditions in pediatric populations is crucial for understanding disease impact.
Purpose of the Study:
- To characterize long-term outcomes following pediatric SARS-CoV-2 infection.
- To compare symptoms, functional status, and quality of life between infected and uninfected children.
Main Methods:
- Cross-sectional analysis of infected and uninfected pediatric cohorts (0-21 years) at baseline.
- Data collection included demographics, medical history, symptoms, physical exams, cardiopulmonary evaluations, and validated psychological/developmental surveys.
- Primary outcomes involved comparing cohort abnormalities across all collected measures.
Main Results:
- Infected participants (n=541) reported more constitutional, HEENT, respiratory, and gastrointestinal symptoms compared to uninfected controls (n=113).
- Infected children experienced worse Patient Reported Outcomes in domains including Pain, Fatigue, Global Health, Physical and Cognitive functioning, Mobility, and Sleep disturbances.
- Cardiopulmonary findings were similar between infected and uninfected cohorts at baseline.
Conclusions:
- Pediatric SARS-CoV-2 infection is associated with increased symptom reporting and diminished quality of life.
- Longitudinal data from the PECOS study will enhance understanding of the long-term effects of COVID-19 in children, aiding in the identification of sequelae and contributing factors.
Background:
PECOS is an ongoing study aimed to characterize long-term outcomes following pediatric SARS-CoV-2 infection.
Methods:
This is a cross-sectional analysis of infected and uninfected cohorts at baseline. Participants (0-21 years) with laboratory-confirmed SARS-CoV-2 infection were enrolled as infected. Uninfected were defined as individuals without history or laboratory evidence of SARS-CoV-2 infection. Outcome measures included demographics, medical history, review of symptoms, physical exam, cardiopulmonary evaluation and validated psychological and developmental surveys. Primary outcomes were cohort comparisons for abnormalities on all measures.
Results:
654 participants (541 infected, 113 uninfected) completed baseline visits by June 30, 2023. Infected participants were more likely to report constitutional (OR: 2.24), HEENT (OR: 3.74); respiratory (OR: 2.41), or gastrointestinal (OR: 2.58) symptoms. Infected had worse scores in domains of Pain, Fatigue, Global Health, Physical and Cognitive functioning, Mobility and Sleep disturbances when compared to uninfected controls using Patient Reported Outcomes. Cardiopulmonary findings were similar among cohorts.
Conclusions:
The first report of this ongoing longitudinal study demonstrates that infected participants were more likely to report symptoms compared to uninfected controls, which may affect performance and quality of life of these individuals. Longitudinal data will increase understanding of long-term effects of SARS-CoV-2 infection in children.
Clinicaltrials:
gov Identifier: NCT04830852 IMPACT: This study establishes a large, diverse, prospective, longitudinal, multi-center cohort of children with history of SARS-CoV-2 infection compared to an uninfected cohort to be followed for 3 years. Cross-sectional cohort analysis at study entry showed infected participants were more likely to report constitutional, respiratory, and GI symptoms compared to uninfected controls. Infected participants were more likely to have significantly worse parent-reported performance in 6 of 10 Patient Reported Outcome Measures domains. Continued study of this cohort will help identify clinical sequelae of COVID-19, characterize the immune response to SARS-CoV-2 infection, and identify potential genetic/immunologic factors associated with long-term outcomes.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Respiratory Syncytial Virus Disease

